
Scientists at the Baylor College of Medicine, University of Texas have developed a device which they claim can identify cancerous …

The FDA has placed a partial hold on clinical trials involving Bristol-Myers Squibb’s immunotherapy treatment, Opdivo, when used in combination …

An anti-TSLP monoclonal antibody jointly developed by Amgen and AstraZeneca’s global biologics and research division, MedImmune, has met its primary …

MSD has announced that it will acquire Rigontec, a three-year old German biotech, in a deal worth an initial €115 …

AstraZeneca has revealed new data supporting the long-term use and efficacy of its cardiovascular drug Brilinta (ticagrelor), showing that the …

French clinical-stage biopharma firm Cellectis has received an order from the FDA to halt its study of CAR T therapy …

Novo Nordisk has resolved a probe by the US Justice Department which accused the Danish drugmaker of illegal marketing activities …

NICE has revealed that the outcome of its consultation process for Ninlaro (ixazomib), Takeda’s treatment for relapsed or refractory multiple …

Back in 2000, Pfizer had a drug that was granted accelerated approval for the treatment of acute myeloid leukaemia (AML) …

Merck KGaA has revealed that it is looking to sell its consumer healthcare business, in order to refocus the business …

The UK Supreme Court has sent shockwaves through the intellectual property world with its recent decision on Eli Lilly v …

NHS Providers has stated that £350 million needs to be injected into the NHS to avoid the ‘humanitarian crisis’ that …

Sanofi’s development of a Zika vaccine, alongside the US’s Biomedical Advanced Research and Development Authority (BARDA), has hit the headlines …

This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its …

Jenny Tragner, director at R&D tax credit consultancy ForrestBrown and member of HMRC’s R&D Consultative Committee, says R&D tax credits …